- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 25.03. | Ferrer signs $122M biobucks deal for ex-US license to Verge's phase 1 ALS therapy | ||
| 25.03. | Novo Nordisk inks $1B Cardior buyout to pump up heart failure plans | ||
| 22.03. | In another step forward for AI, UW researchers deliver antibody-generating model | ||
| 22.03. | FDA elevates recall of 6.6M Vyaire Medical emergency bag valve masks | ||
| 22.03. | Brii goes all in on HPV, punting HIV, depression, lung disease programs to potential partners | ||
| 22.03. | Intellia opts out of hemophilia gene editing work with Regeneron | ||
| 22.03. | After GSK acquisition, Bellus CEO seeks work opportunities for displaced staff | ||
| 22.03. | Nkarta's blood cancer CAR stalls again, with falling response rate forcing it out of the race | ||
| 21.03. | J&J's Abiomed sees serious Impella recall linked to heart perforations, 49 deaths | ||
| 21.03. | Neuralink video shows human brain-computer interface user playing game of chess | ||
| 21.03. | Boundless Bio eyes $88M offering as spring biotech IPO market blooms | ||
| 21.03. | Innate drops monotherapy plans for lymphoma med lacutamab 2 months after FDA lifts hold | ||
| 20.03. | Johnson Matthey sells off medtech metal manufacturing unit to Montagu in $700M private equity deal | ||
| 20.03. | Nvidia unveils generative AI programs for drug molecule design, protein predictions | ||
| 20.03. | Acelyrin adds proof-of-concept TED data to recent readout pile, cementing challenge to Amgen | ||
| 19.03. | Bioforum expands leadership team with new president Michael Goedde | ||
| 19.03. | ProofPilot to integrate patient verification tools in partnership with Verified Clinical Trials | ||
| 19.03. | Surgical robot startup Mendaera picks up Avail Medsystems' COVID-era virtual OR assets | ||
| 19.03. | Eliem cuts in on Tango, proposing acquisition after strategic review | ||
| 19.03. | Innovent's anti-VEGF drug matches Eylea in phase 2 eye disease trial | ||
| 19.03. | Siemens Healthineers to shutter Fast Track PCR diagnostic unit in post-COVID slim down | ||
| 19.03. | Seelos' IV-administered sugar therapy fails to improve ALS severity in midstage trial | ||
| 19.03. | Crinetics pads case for oral hormone disorder drug, showing regulation of key biomarker in phase 3 | ||
| 19.03. | Bayer ready to take rival to Astellas' Veozah to regulators after phase 3 hat trick | ||
| 19.03. | AstraZeneca melds with Fusion in $2B radiopharma buyout |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
